Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.

Saved in:
Bibliographic Details
Title: Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.
Authors: Foldi J; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Hogan G; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Johansen Taber K; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., LaBella M; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Sadler B; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Patel R; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Balic M; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Haslem D; Oncology Service Line, Intermountain Healthcare, Saint George, UT, USA., Mazo Canola M; Division of Hematology and Oncology, Mays Cancer Center, University of Texas at San Antonio, San Antonio, TX, USA., Peih-Ying Tsai J; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA., Cusick T; Department of Surgery, Ascension Via Christi Hospitals Wichita, Inc.., Wichita, KS, USA., Nathwani N; Carolina Blood and Cancer Care Associates, Lancaster, SC, USA., Naito Y; Department of Medical Oncology, Department of General Internal Medicine, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Funasaka C; Department of Medical Oncology, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Wong K; Department of Medical Oncology, Providence Saint Joseph's Medical Center, Burbank, CA, USA., Ham A; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Acevedo A; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Battey CJ; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Gould GM; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Muzzey D; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Jasper J; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.
Source: Future oncology (London, England) [Future Oncol] 2026 Jul; Vol. 22 (16), pp. 1985-1996. Date of Electronic Publication: 2026 Jun 21.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42324681
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Foldi+J%22">Foldi J</searchLink>; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hogan+G%22">Hogan G</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Johansen+Taber+K%22">Johansen Taber K</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22LaBella+M%22">LaBella M</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Sadler+B%22">Sadler B</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Patel+R%22">Patel R</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Balic+M%22">Balic M</searchLink>; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Haslem+D%22">Haslem D</searchLink>; Oncology Service Line, Intermountain Healthcare, Saint George, UT, USA.<br /><searchLink fieldCode="AU" term="%22Mazo+Canola+M%22">Mazo Canola M</searchLink>; Division of Hematology and Oncology, Mays Cancer Center, University of Texas at San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Peih-Ying+Tsai+J%22">Peih-Ying Tsai J</searchLink>; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Cusick+T%22">Cusick T</searchLink>; Department of Surgery, Ascension Via Christi Hospitals Wichita, Inc.., Wichita, KS, USA.<br /><searchLink fieldCode="AU" term="%22Nathwani+N%22">Nathwani N</searchLink>; Carolina Blood and Cancer Care Associates, Lancaster, SC, USA.<br /><searchLink fieldCode="AU" term="%22Naito+Y%22">Naito Y</searchLink>; Department of Medical Oncology, Department of General Internal Medicine, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Funasaka+C%22">Funasaka C</searchLink>; Department of Medical Oncology, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Wong+K%22">Wong K</searchLink>; Department of Medical Oncology, Providence Saint Joseph's Medical Center, Burbank, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ham+A%22">Ham A</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Acevedo+A%22">Acevedo A</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Battey+CJ%22">Battey CJ</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Gould+GM%22">Gould GM</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Muzzey+D%22">Muzzey D</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Jasper+J%22">Jasper J</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2026 Jul; Vol. 22 (16), pp. 1985-1996. <i>Date of Electronic Publication: </i>2026 Jun 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42324681
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14796694.2026.2690165
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1985
    Titles:
      – TitleFull: Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Foldi J
      – PersonEntity:
          Name:
            NameFull: Hogan G
      – PersonEntity:
          Name:
            NameFull: Johansen Taber K
      – PersonEntity:
          Name:
            NameFull: LaBella M
      – PersonEntity:
          Name:
            NameFull: Sadler B
      – PersonEntity:
          Name:
            NameFull: Patel R
      – PersonEntity:
          Name:
            NameFull: Balic M
      – PersonEntity:
          Name:
            NameFull: Haslem D
      – PersonEntity:
          Name:
            NameFull: Mazo Canola M
      – PersonEntity:
          Name:
            NameFull: Peih-Ying Tsai J
      – PersonEntity:
          Name:
            NameFull: Cusick T
      – PersonEntity:
          Name:
            NameFull: Nathwani N
      – PersonEntity:
          Name:
            NameFull: Naito Y
      – PersonEntity:
          Name:
            NameFull: Funasaka C
      – PersonEntity:
          Name:
            NameFull: Wong K
      – PersonEntity:
          Name:
            NameFull: Ham A
      – PersonEntity:
          Name:
            NameFull: Acevedo A
      – PersonEntity:
          Name:
            NameFull: Battey CJ
      – PersonEntity:
          Name:
            NameFull: Gould GM
      – PersonEntity:
          Name:
            NameFull: Muzzey D
      – PersonEntity:
          Name:
            NameFull: Jasper J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1